Ovid Therapeutics Inc (US: OVID) — Healthcare · Share Price, Chart & Market Data
About: Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.63 (+0.96%)
OVIDOvid Therapeutics Inc
Loading watchlist status…
Trade OVID now
Ovid Therapeutics Inc share price
OVID price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 5:40 pm GMT+0
OVID price performance
-7.895%
5D
14.13%
1M
49.148%
YTD
650%
1Y
OVID price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 5:40 pm GMT+0
OVID details
OVID Market Signals